K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

Read here for an analysis of Koninklijke Philips' performance and 2025 outlook, highlighting challenges and revised sales ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Charting, Price Performance, News & Related Contracts.

Healthcare finances have been steady in the past few months, and many healthcare provider's main focus is getting back to ...

The big banks brought their A-game in Q4. Earnings reports from the likes of JPMorgan Chase (JPM), Wells Fargo (WFC), Goldman Sachs (GS), Citigroup (C), Bank of America (BAC), and Morgan Stanley ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

"We sit at the intersection of those large scale incumbents and entrepreneurs, to help bridge the gap," Josh Flum, Managing Partner at LRVHealth, tells Bloomberg Intelligence in this episode of the ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...